The Prostate Cancer Treatment Landscape

This program was possible with support from Bayer. Alicia Morgans, MD, MPH, reviews the incidence of prostate cancer and risk factors associated with the disease.

This program was possible with support from Bayer. Clinical insights on the typical presentation of prostate cancer and how the disease is diagnosed.

Reginald Tucker-Seeley, MA, ScM, ScD, gives an overview of the screening and diagnosis process of prostate cancer.

Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.